The potency of allospecific tregs cells appears to correlate with T cell receptor functional avidity

American Journal of Transplantation

Volumn 11, Issue 8, 2011, Pages 1610-1620

  Tsang, J Y S ^a,b   Ratnasothy, K ^c   Li, D ^a   Chen, Y ^a,b   Bucy, R P ^d   Lau, K F ^e   Smyth, L ^c   Lombardi, G ^c   Lechler, R ^c   Tam, P K H ^a  

^a Department of Surgery ^*  (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d University of Alabama at Birmingham   (United States)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Functional avidity; regulatory T cells; T cell receptor; transplantation

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; GRAFT REJECTION; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO CULTURE; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SKIN TRANSPLANTATION; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; FLOW CYTOMETRY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY;

EID: 79961049730     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03650.x     Document Type: Article

References (33)

1. Long E, Wood KJ,. Regulatory T cells in transplantation: Transferring mouse studies to the clinic. Transplantation 2009; 88: 1050-1056.
2. Lechler RI, Garden OA, Turka LA,. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003; 3: 147-158. (Pubitemid 37328692)
3. Sagoo P, Lombardi G, Lechler RI,. Regulatory T cells as therapeutic cells. Curr Opin Organ Transplant 2008; 13: 645-653.
4. Riley JL, June CH, Blazar BR,. Human T regulatory cell therapy: Take a billion or so and call me in the morning. Immunity 2009; 30: 656-665.
5. Thornton AM, Shevach EM,. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183-190. (Pubitemid 30012989)
6. Joffre O, Santolaria T, Calise D, et al,. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008; 14: 88-92.
7. Tang Q, Henriksen KJ, Bi M, et al,. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455-1465. (Pubitemid 38780401)
8. Tarbell KV, Petit L, Zuo X, et al,. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 2007; 204: 191-201. (Pubitemid 46148769)
9. Tsang JY, Tanriver Y, Jiang S, et al,. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 2008; 118: 3619-3628.
10. Jiang S, Tsang J, Game DS, Stevenson S, Lombardi G, Lechler RI,. Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance. Transplantation 2006; 82: 1738-1743. (Pubitemid 46035661)
11. Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA,. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 2005; 175: 3053-3059. (Pubitemid 41170524)
12. Alexander-Miller MA,. High-avidity CD8+ T cells: Optimal soldiers in the war against viruses and tumors. Immunol Res 2005; 31: 13-24. (Pubitemid 40065421)
13. Varela-Rohena A, Molloy PE, Dunn SM, et al,. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med 2008; 14: 1390-1395.
14. Derby M, Alexander-Miller M, Tse R, Berzofsky J,. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J Immunol 2001; 166: 1690-1697. (Pubitemid 32114651)
15. Jorritsma A, Gomez-Eerland R, Dokter M, et al,. Selecting highly affine and well-expressed TCRs for gene therapy of melanoma. Blood 2007; 110: 3564-3572. (Pubitemid 350159623)
16. Honjo K, Xu X, Bucy RP,. CD4+ T-cell receptor transgenic T cells alone can reject vascularized heart transplants through the indirect pathway of alloantigen recognition. Transplantation 2004; 77: 452-455. (Pubitemid 38209750)
17. Inaba K, Inaba M, Romani N, et al,. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693-1702.
18. Tsang JY, Tanriver Y, Jiang S, et al,. Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression. Transpl Immunol 2009; 21: 203-209.
19. Peterson DA, DiPaolo RJ, Kanagawa O, Unanue ER,. Cutting edge: Negative selection of immature thymocytes by a few peptide-MHC complexes: Differential sensitivity of immature and mature T cells. J Immunol 1999; 162: 3117-3120. (Pubitemid 29313554)
20. Lennon GP, Bettini M, Burton AR, et al,. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 2009; 31: 643-653.
21. Kang SM, Tang Q, Bluestone JA,. CD4+CD25+ regulatory T cells in transplantation: Progress, challenges and prospects. Am J Transplant 2007; 7: 1457-1463. (Pubitemid 46776267)
22. Roncarolo MG, Battaglia M,. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007; 7: 585-598. (Pubitemid 47123554)
23. Alexander-Miller MA, Leggatt GR, Berzofsky JA,. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci U S A 1996; 93: 4102-4107. (Pubitemid 26144250)
24. Zeh HJ III, Perry-Lalley D, Dudley ME, Rosenberg SA, Yang JC,. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol 1999; 162: 989-994. (Pubitemid 29035425)
25. Oling V, Geubtner K, Ilonen J, Reijonen H,. A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: A study of human autoreactive CD4+T cells specific for GAD65. Autoimmunity 2010; 43: 573-582.
26. Apostolou I, Sarukhan A, Klein L, von Boehmer H,. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002; 3: 756-763.
27. Bensinger SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM,. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med 2001; 194: 427-438. (Pubitemid 32835039)
28. Jordan MS, Boesteanu A, Reed AJ, et al,. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2: 301-306. (Pubitemid 33706340)
29. Wilson DB, Wilson DH, Schroder K, et al,. Specificity and degeneracy of T cells. Mol Immunol 2004; 40: 1047-1055. (Pubitemid 38221185)
30. Burlingham WJ, Goulmy E,. Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens. Hum Immunol 2008; 69: 728-731.
31. Cai J, Lee J, Jankowska-Gan E, et al,. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 2004; 199: 1017-1023. (Pubitemid 38481093)
32. Rubinstein MP, Kadima AN, Salem ML, et al,. Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity. J Immunol 2003; 170: 1209-1217. (Pubitemid 36139485)
33. Schaft N, Willemsen RA, de Vries J, et al,. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes. J Immunol 2003; 170: 2186-2194. (Pubitemid 36197443)